Deborah Weinswig, mentioned 7 times across podcast episodes and expert conversations analyzed by Sonic.
Deborah Weinshwig of CoreSight Research Group observes that consumers are showing less willingness to trade down from preferred retail stores or from branded products to private labels.
The widespread use of GLP-1 medications is creating a significant shift in consumer apparel demand, with 70% of users changing two or more clothing sizes and 50% purchasing new clothing as a result.
One-fifth of the U.S. population is currently on or has been on GLP-1 drugs.